Medicenna Reports First Quarter Fiscal 2025 Financial Results and Announces First Complete Responder with MDNA11 Monotherapy Aug 1, 2024 07:00AM
Medicenna Therapeutics Reports Fiscal Year 2024 Financial Results and Operational Highlights Jun 27, 2024 08:18AM
Form SC 13G Medicenna Therapeutics Filed by: RA CAPITAL MANAGEMENT, L.P. May 10, 2024 05:53PM